BIVI
BIVI clinical trials: BIOVIE INC.
Every trial on ClinicalTrials.gov where BIOVIE INC. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 8
- Trials linked
- 6
- As lead sponsor
- 2
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
BIVI on the catalyst calendar · BIVI registry changes
- Primary completion Aug 6, 2026ActualPhase 2NCT06847191NE3107 in Adults With Neurological Symptoms of Long COVIDBioVie Inc. · Long COVIDCompletedBIVILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 1, 2026ActualPhase 2NCT06757010A Study of NE3107 in Early Parkinson'sBioVie Inc. · Parkinsons Disease (PD)CompletedBIVILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 8, 2023ActualPhase 2NCT04112199A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory AscitesBioVie Inc. · AscitesTerminatedBIVILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2023ActualPhase 3NCT04669028A Phase 3 Study of NE3107 in Probable Alzheimer's DiseaseBioVie Inc. · Alzheimer DiseaseCompletedBIVILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 21, 2022ActualPhase 1/Phase 2NCT05083260NE3107 Activity and Safety in Patients With Parkinson's Disease Using LevodopaBioVie Inc. · Parkinson DiseaseCompletedBIVILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 1, 2019ActualPhase 2NCT03107091Continuous Infusion Terlipressin for Patients With Cirrhosis and Refractory AscitesBioVie Inc. · CirrhosisCompletedBIVILead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 21, 2025ActualPhase 2NCT05970575Insulin-sensitizing NE3107 in Improving Sleep and Fatigue in Subjects With Traumatic Brain InjuryNeurological Associates of West Los Angeles · Traumatic Brain InjuryTerminatedBIVICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 20, 2022ActualPhase 2NCT05227820Insulin-Sensitizing Anti-Inflammatory Small Molecule for Investigative Treatment of DementiaNeurological Associates of West Los Angeles · Alzheimer DiseaseCompletedBIVICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 8 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner